July 8, 2020 / 11:30 AM / a month ago

BRIEF-Sanofi Canada Says Sarclisa Available In Canada For Patients With Relapsed, Refractory Multiple Myeloma

July 8 (Reuters) - Sanofi SA:

* SANOFI CANADA - SARCLISA (ISATUXIMAB FOR INJECTION) AVAILABLE IN CANADA FOR PATIENTS WITH RELAPSED, REFRACTORY MULTIPLE MYELOMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below